Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01838239 · ClinicalTrials.gov registry record · NA
Development of a Metabolic Assessment Tool for Chronic Kidney Disease
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01838239 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 12 participants.
The verdict
NCT01838239, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the variation between individuals in blood lipid metabolites, and the changes in these metabolites in response to omega-3 fatty acids in patients with immunoglobulin A nephropathy (IgAN) and in healthy subjects. The hypothesis is that measuring variation among individuals and changes in response to omega-3 fatty acids comprehensively by using metabolomics will help to identify those individuals who are responders and those who are non-responders to omega-3 fatty acids as an anti-inflammatory intervention.
Interventions
- DIETARY_SUPPLEMENT Fish Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2008-06 |
| Est. Completion | 2011-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01838239
The ClinicalTrials.gov registry entry for NCT01838239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fish Oil is the first listed.
NCT01838239 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01838239 about?
NCT01838239 is a clinical study titled "Development of a Metabolic Assessment Tool for Chronic Kidney Disease". The purpose of this study is to examine the variation between individuals in blood lipid metabolites, and the changes in these metabolites in response to omega-3 fatty acids in patients with immunoglobulin A nephropathy (IgAN) and in healthy subjects. The hypothesis is that measuring variation among...
What is the current status of trial NCT01838239?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2008-06. Estimated completion is 2011-06.
What interventions are being tested in trial NCT01838239?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01838239?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.